Chintan Desai, ASEAN CEO, GE Healthcare, Singapore
Healthcare systems across the world were initially caught off-guard when tasked with this unprecedented crisis, which required the urgent mobilisation of resources and affected the whole population.
Unfortunately, the fight is still far from over. In recent weeks, new, more contagious variants of the virus have emerged in countries such as India, the United Kingdom, and South Africa. These intractable variants have spread rapidly across the region sending countries into another round of lockdowns, outpacing the global vaccination programme determined to be the best weapon in fighting the pandemic.
Global social distancing, infection control, and lockdown measures have created a plethora of challenges for the healthcare industry as it looks to tackle the influx of patients while continuing to deliver ongoing care that remains critical. However, for an industry that thrives through constant discovery, the eventual speed and scale of its response to COVID-19 has been nothing short of remarkable.
The pandemic has proved to be a powerful catalyst in bringing forward the industry’s digitalisation. We are now seeing the convergence of digital technologies with healthcare, to make medicine more personalised and precise.
As the situation evolves, it is important we continue to invest in building new capabilities today so that we have the capacity to deal with the emergencies of tomorrow. Here are three trends I believe will permanently drive and shape the way healthcare is delivered and received, for the future of digital health.
1. Accelerating precision health by leveraging digital technology
This story is from the BioSpectrum Asia July 2021 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the BioSpectrum Asia July 2021 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Ushering Fourth Industrial Revolution in Telangana
Taking advantage of the 21st edition of BioAsia 2024 at the Hyderabad International Convention Centre (HICC) in Madhapur, the Government of Telangana, a southern state in India, leveraged the confluence of the global platform to spearhead initiatives aimed at propelling the state into the forefront of the Fourth Industrial Revolution (C4IR).
How Indian Biotech Investments are on a Doubling Spree
A latest report by Ankur Capital provides a closer look at the investments made in biotechnology in the last decade in the country.
"AI will be integrally involved in not only the diagnosis of cancer but also in determining the prognosis and best therapeutic option”
South Korea-based Deep Bio, a pioneering artificial intelligence (AI) healthcare firm focused on cancer pathology, is making waves in the industry.
"Because of its specificity and selectivity, ADCS have the potential to reduce adverse side effects and improve patient survival"
Japan-headquartered Daiichi Sankyo, the global healthcare company, launched its subsidiary Daiichi Sankyo Singapore Pte. Ltd. to bridge unmet needs in oncology.
Can Test, Treat, Track Beat Malaria?
Malaria has long been a major public health concern in the Asia Pacific region, particularly in South East Asia (SEA) affecting millions of people.
Engineering CAR T cell sharpshooters
Approved CAR T-cell therapies have shown remarkable results in patients with certain types of blood cancers.
Addressing Challenges in Cell Therapy Manufacturing
Even with significant advancements, there are still anumber of issues with cell therapy manufacturing that need to be resolved as production grows.
"We anticipate India will adopt decentralised models for managing CGTs, ensuring closer proximity between patients and treatment facilities"
Cell and gene therapy (CGT) expert from Germany, Miltenyi Biotec has recently announced its entry into the Indian market to provide researchers, scientists and clinicians easier access to expertise, research, and manufacturing solutions.
Addressing Accessibility and Affordability of CELL & GENE THERAPIES
Cell and gene therapies (CGT) are one of the hottest sectors in the pharmaceutical industry.
Korea designs sweat resistant wearable robot sensor
New electromyography (EMG) sensor technology that allows the long-term stable control of wearable robots and is not affected by the wearer's sweat and dead skin has gained attention recently.